Jones Hill Capital’s Immunic IMUX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-539,814
Closed -$8.3M – 41
2026
Q2
$8.3M Buy
+539,814
New +$6.66M 1.76% 17

Other funds holding IMUX

Jones Hill Capital's IMUX Position: Q3 2026 in Review

Jones Hill Capital sold out of Immunic (IMUX) in Q3 2026, closing a stake of 539,814 shares — an estimated $8.3M sold.

Jones Hill Capital first reported a position in IMUX in Q2 2026 and held it in 1 quarter. The position peaked at $8.3M in Q2 2026. 49 funds tracked by Wall St. Rank hold IMUX as of Q3 2026.

  • Jones Hill Capital reported no remaining Immunic position as of Q3 2026 after selling out during the quarter.
  • Jones Hill Capital sold 539,814 Immunic shares in Q3 2026, an estimated $8.3M.
  • Jones Hill Capital first reported a position in Immunic in Q2 2026 and held it in 1 quarter.
  • Jones Hill Capital's Immunic position peaked at $8.3M in Q2 2026.
  • 49 funds tracked by Wall St. Rank held Immunic as of Q3 2026.

Based on Jones Hill Capital's 13F filing for Q3 2026, filed 13 Nov 2026.